We demonstrate that CD73 expression on T cells sustained by TGF-β in the tumor microenvironment is responsible for mediating resistance to the therapeutic activity of agonist antibodies against a TNFR superfamily member across several tumor types. Here, NT5E is linked to neoplasm.